Radiotherapy Plus Temozolomide with or Without Anlotinib in H3K27M-mutant Diffuse Midline Glioma: A Retrospective Cohort Study
CNS NEUROSCIENCE & THERAPEUTICS（2024）
Key words
adverse events,anlotinib,prognosis,survival,targeted therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined